Medicus Sciences (MSAC) Signs LOI with Anteris Technology
by Marlena Haddad on 2022-02-08 at 10:25am

Medicus Sciences Acquisition Corp. (NASDAQ:MSAC) filed an 8-K this morning disclosing that it has signed a non-binding letter of intent (LOI) for a potential business combination with medical technology company Anteris Technologies Ltd (“Anteris”), but did not provide any other details.

Australia-based Anteris is a structural heart company helping healthcare professionals to create life-changing outcomes for patients through its Better Science and Better Design technologies.

SPACs are not typically obligated to disclose discussions at this stage.  However, in Anteris’ case, it was required to make a public announcement disclosing that it had been approached by the company due to applicable Australian securities laws.

This is not the same as a definitive agreement (DA) and Medicus Sciences will remain in our “searching” column until a DA is actually singed and announced. There is no guarantee that the parties will come to an agreement on a definitive merger and we have seen LOIs announced in the past only for the SPAC to sign a DA with a different target weeks later.

Medicus has a little over a year left to find a target with a deadline of February 18, 2023, giving it plenty of time to sign a DA.

 

 

Medicus Sciences (MSAC) Signs LOI with Anteris Technology
Recent Posts
by Nicholas Alan Clayton on 2025-07-03 at 12:54pm

Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...

by Nicholas Alan Clayton on 2025-07-03 at 8:27am

At the SPAC of Dawn One of the biggest sources of uncertainty in the SPAC market in recent years has been regulatory changes, but new shifts could be in its favor. SEC Chairman Paul Atkins told CNBC yesterday that the commission would review the rules for SPACs after “rather controversial” changes to the rules passed...

by Nicholas Alan Clayton on 2025-07-02 at 12:13pm

McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...

by Nicholas Alan Clayton on 2025-07-02 at 8:29am

At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....

by Nicholas Alan Clayton on 2025-07-02 at 6:28am

EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved